Package-Ref? Colorectal cancer SDC2/TFPI2 for Methylation control
CBPE0412
詢 價(jià)
索取COA
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| Introduction | ||||||
| Description | DNA methylation is an epigenetic modification, a form of chemical modification of DNA, which refers to the carbon 5 of cytosine in the genomic CpG dinucleotide under the action of DNA methyltransferase. covalently bonded to a methyl group. It can change genetic expression without changing the DNA sequence. This package contains multiple detection samples for Colorectal cancer, We use simulated clinical cell lines to prepare them. If you are testing SDC2/TFPI2, you can choose this product. |
|||||
| Technical Data | ||||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
|
質(zhì)控品 |
CBPE0412-1 | 結(jié)直腸癌-SDC2,TFPI2陽(yáng)性甲基化 | SDC2 Methylation with Positive control | Chr8:97506434-97506502(hg19) | N/A | |
| TFPI2 Methylation with Positive control | Chr7:93519461-93519624(hg19) | N/A | ||||
| CBPE0412-2 | 結(jié)直腸癌-SDC2,TFPI2陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
| TFPI2 Methylation with Negative control | Chr7:93519461-93519624(hg19) | N/A | ||||
| CBPE0412-3 | 結(jié)直腸癌-SDC2陰性甲基化，TFPI2陽(yáng)性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | 0.19% | ||
| TFPI2 Methylation with Positive control | Chr7:93519461-93519624(hg19) | 33.09% | ||||
| CBPE0412-4 | 結(jié)直腸癌-TFPI2陰性甲基化，SDC2陽(yáng)性甲基化 | SDC2 Methylation with Positive control | Chr8:97506434-97506502(hg19) | 49.09% | ||
| TFPI2 Methylation with Negative control | Chr7:93519461-93519624(hg19) | 0.08% | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽(yáng)SDC2-參考品 |
單陽(yáng)SDC2 區(qū)段-強(qiáng)陽(yáng)性參考品-1 |
CBPE0412-5 | SDC2強(qiáng)陽(yáng)性甲基化參考品，TFPI2陰性甲基化 | SDC2 Methylation Reference Standard with 45.00% | Chr8:97506434-97506502(hg19) | 49.09% |
| TFPI2 Methylation with Negative control | Chr7:93519461-93519624(hg19) | 0.08% | ||||
|
單陽(yáng)SDC2 區(qū)段-強(qiáng)陽(yáng)性參考品-2 |
CBPE0412-6 | SDC2強(qiáng)陽(yáng)性甲基化參考品，TFPI2陰性甲基化 | SDC2 Methylation Reference Standard with 10.00% | Chr8:97506434-97506502(hg19) | 9.12% | |
| TFPI2 Methylation Negative Reference Standard | Chr7:93519461-93519624(hg19) | N/A | ||||
|
單陽(yáng)SDC2 區(qū)段-弱陽(yáng)性參考品 |
CBPE0412-7 | SDC2弱陽(yáng)性甲基化參考品，TFPI2陰性甲基化 | SDC2 Methylation Reference Standard with 3.00% | Chr8:97506434-97506502(hg19) | N/A | |
| TFPI2 Methylation Negative Reference Standard | Chr7:93519461-93519624(hg19) | N/A | ||||
|
單陽(yáng)SDC2 區(qū)段-檢測(cè)限參考品 |
CBPE0412-8 | SDC2檢測(cè)限甲基化參考品，TFPI2陰性甲基化 | SDC2 Methylation Reference Standard with 1.00% | Chr8:97506434-97506502(hg19) | 1.17% | |
| TFPI2 Methylation Negative Reference Standard | Chr7:93519461-93519624(hg19) | N/A | ||||
|
單陽(yáng)SDC2 區(qū)段-陰性參考品 |
CBPE0412-9 | 結(jié)直腸癌-SDC2,TFPI2陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | |
| TFPI2 Methylation with Negative control | Chr7:93519461-93519624(hg19) | N/A | ||||
|
單陽(yáng)SDC2 區(qū)段-精密度參考品 |
CBPE0412-10 | SDC2弱陽(yáng)性甲基化參考品，TFPI2陰性甲基化 | SDC2 Methylation Reference Standard with 3.00% | Chr8:97506434-97506502(hg19) | N/A | |
| TFPI2 Methylation Negative Reference Standard | Chr7:93519461-93519624(hg19) | N/A | ||||
| CBPE0412-11 | 結(jié)直腸癌-SDC2,TFPI2陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
| TFPI2 Methylation with Negative control | Chr7:93519461-93519624(hg19) | N/A | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽(yáng)TFPI2-參考品 |
單陽(yáng)TFPI2 區(qū)段-強(qiáng)陽(yáng)性參考品-1 |
CBPE0412-12 | TFPI2強(qiáng)陽(yáng)性甲基化參考品，SDC2陰性甲基化 | TFPI2 Methylation Reference Standard with 30.00% | Chr7:93519461-93519624(hg19) | 33.09% |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | 0.19% | ||||
|
單陽(yáng)TFPI2 區(qū)段-強(qiáng)陽(yáng)性參考品-2 |
CBPE0412-13 | TFPI2強(qiáng)陽(yáng)性甲基化參考品，SDC2陰性甲基化 | TFPI2 Methylation Reference Standard with 10.00% | Chr7:93519461-93519624(hg19) | 10.94% | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
|
單陽(yáng)TFPI2 區(qū)段-弱陽(yáng)性參考品 |
CBPE0412-14 | TFPI2弱陽(yáng)性甲基化參考品，SDC2陰性甲基化 | TFPI2 Methylation Reference Standard with 3.00% | Chr7:93519461-93519624(hg19) | N/A | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
|
單陽(yáng)TFPI2 區(qū)段-檢測(cè)限參考品 |
CBPE0412-15 | TFPI2檢測(cè)限甲基化參考品，SDC2陰性甲基化 | TFPI2 Methylation Reference Standard with 1.00% | Chr7:93519461-93519624(hg19) | 1.09% | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
|
單陽(yáng)TFPI2 區(qū)段-陰性參考品 |
CBPE0412-16 | 結(jié)直腸癌-SDC2,TFPI2陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | |
| TFPI2 Methylation with Negative control | Chr7:93519461-93519624(hg19) | N/A | ||||
|
單陽(yáng)TFPI2 區(qū)段-精密度參考品 |
CBPE0412-17 | TFPI2弱陽(yáng)性甲基化參考品，SDC2陰性甲基化 | TFPI2 Methylation Reference Standard with 3.00% | Chr7:93519461-93519624(hg19) | N/A | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
| CBPE0412-18 | 結(jié)直腸癌-SDC2,TFPI2陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
| TFPI2 Methylation with Negative control | Chr7:93519461-93519624(hg19) | N/A | ||||
| 備注 | 1. 質(zhì)控品也叫準(zhǔn)確度標(biāo)準(zhǔn)品，用于定性判斷； 2. 參考品用于定性和定量的判斷，其中強(qiáng)陽(yáng)、弱陽(yáng)、檢測(cè)限、精密度、特異性的判定需要視具體項(xiàng)目而定，本產(chǎn)品的判定僅為內(nèi)部標(biāo)準(zhǔn)； 3. 質(zhì)控品用于性能評(píng)價(jià)，出廠檢，試劑盒日常檢測(cè)判定，參考品用于性能評(píng)價(jià)，出廠檢； 4.上述產(chǎn)品只展示了部分結(jié)果，甲基化程度可以定制。 |
|||||
| Product Information | ||||||
| Intended Use | Research Use Only | |||||
| Concentration | Download for COA | |||||
| Purity | Download for COA | |||||
| DNA electrophoresis | Download for COA | |||||
| Format | Genomic DNA | |||||
| Unit Size | 1ug | |||||
| Storage | 4°C | |||||
| Expiry | 36 months from the date of manufacture | |||||
| Remark | The data in the instruction manual is the data of a single test, and the specific data of each batch is subject to delivery. | |||||
